Unusually aggressive type 1 gastric carcinoid: A case report with a review of the literature

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 5, 2012, Pages 589-593

  Spampatti, Matilde Pia ^a   Massironi, Sara ^a   Rossi, Roberta Elisa ^a   Conte, Dario ^a   Sciola, Valentina ^a   Ciafardini, Clorinda ^a   Ferrero, Stefano ^a,b   Lodi, Lucia ^c   Peracchi, Maddalena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c BUSTO ARSIZIO HOSPITAL   (Italy)

Author keywords

atrophic gastritis; carcinoid metastases; gastric carcinoids; neuroendocrine tumors; octreotide test

Indexed keywords

ANGIOPEPTIN; CHROMOGRANIN A; CYANOCOBALAMIN; GASTRIN; KI 67 ANTIGEN; OCTREOTIDE;

ADULT; CANCER CLASSIFICATION; CANCER INVASION; CANCER SIZE; CASE REPORT; DIABETES MELLITUS; ENDOSCOPIC ECHOGRAPHY; ENTERIC FEEDING; ERECTILE DYSFUNCTION; ESOPHAGOGASTRODUODENOSCOPY; FOLLOW UP; GASTRECTOMY; GASTRIN BLOOD LEVEL; HUMAN; IMMUNOREACTIVITY; JEJUNOSTOMY; LAPAROTOMY; LIVER LOBECTOMY; LIVER METASTASIS; LYMPHADENOPATHY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; REVIEW; STOMACH ANTRUM RESECTION; STOMACH BIOPSY; STOMACH CARCINOID; STOMACH LESION; STOMACH POLYP; TREATMENT DURATION; TREATMENT REFUSAL; TUMOR DIFFERENTIATION;

CARCINOID TUMOR; DISEASE PROGRESSION; ENDOSONOGRAPHY; FATAL OUTCOME; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84859349068     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328350fae8     Document Type: Review

References (29)

1. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717-1751. (Pubitemid 40692562)
2. Modlin IR, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surgical Oncology 2003; 12:153-172. (Pubitemid 37289020)
3. Bordi C. Gastric carcinoids. Ital J Gastroenterol Hepatol 1999; 31:94-97.
4. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, patology, and behavior. World J Surg 1996; 20:168-172. (Pubitemid 26069482)
5. Granberg D,Wilander E, Stridsberg M, Granerus G, Skogseid B, Öberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998; 43:223-228. (Pubitemid 28348325)
6. Carney JA, Go VLW, Fairbanks VF, Moore SB, Alport EC, Nora FE. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 1983; 99:761-766. (Pubitemid 14248401)
7. Thomas RM, Baybick JH, Elsayed AM, Sobin LH. An Immunohistochemical and Clinicopathologic Study of 104 patients. Cancer 1994; 73:2053-2058. (Pubitemid 24107957)
8. Borch K, Ahren B, Ahlman H, Falkmer S, Granerus G, Grimelius L. Gastric carcinoids. Biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005; 242:64-73. (Pubitemid 40917969)
9. Rindi G. The ENETS guidelines: the new TNM classification system. Tumori 2010; 96:806-809.
10. Massironi S, Conte D, Sciola V, Spampatti MP, Ciafardini C, Valenti L, et al. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors. Am J Gastroenterol 2010; 105:2072-2078.
11. Rusniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, et al. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 2006; 84:158-164. (Pubitemid 46361049)
12. Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Kida M, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003; 35:203-206. (Pubitemid 36292294)
13. Varas MJ, Gornals JB, Pons C, Espinós JC, Abad R, Lorente FJ, et al. Usefulness of endoscopic ultrasonography for selecting carcinoid tumors as candidates to endoscopic resection. Rev Esp Enferm Dig 2010; 102:577-582.
14. Higham A, Dimaline R, Varro A, Attwood S, Armstrong G, Dockray GJ, et al. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology 1998; 114: 817-822. (Pubitemid 28160417)
15. Fayyaz M, Mehboob S, Andersen V, Sitrin MD. Extended octreotide suppression test to determine hormone responsiveness of multiple type I gastric carcinoid tumors. Dig Dis Sci 2007; 52:1579-1585. (Pubitemid 46776505)
16. Ozao-Choy J, Burch K, Strauchen JH,Warner RR, Divino CM. Laparoscopic antrectomy for the treatment of type 1 gastric carcinoid tumors. J Surg Res 2010; 162:22-25.
17. Ahlman H, Kolby L, Lundell L, Olbe L, Wängberg B, Granérus G, et al. Clinical management of gastric carcinoids tumors. Digestion 1994; 55: 77-85.
18. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999; 116:532-542. (Pubitemid 29106760)
19. Hirschowitz BI. Clinical aspects of ECL-cell abnormalities. Yale J Biol Med 1998; 71:303-310. (Pubitemid 29384199)
20. Qvigstad G, Falkmer S, Westre B, Waldum HL. Clinical and histopathological tumour progression in ECL cell carcinoids (''ECLomas''). APMIS 1999; 107:1085-1092. (Pubitemid 30016633)
21. Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS 2002; 110:132-139. (Pubitemid 34327151)
22. Fykse V, Sandvik AK, Qvigstad G, Falkmer SE, Syversen U, Waldum HL. Treatment of ECL carcinoids with octreotide LAR. Scand J Gastroenterol 2004; 39:621-628. (Pubitemid 38916236)
23. Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L. Treatment of type II gastric carcinoid tumors with somatostatin a analogues. N Engl J Med 2000; 343:551-554. (Pubitemid 30650750)
24. Delle Fave G, Capurso G, Milione M, Panzuto F. Endocrine tumours of the stomach. Dig Liver Dis 2005; 19:659-673. (Pubitemid 41614115)
25. Tamler R, Deveney T. Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know. Postgrad Med 2010; 122:165-175.
26. Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumors. Digestion 1995; 56:455-462.
27. Modlin IM, Lye KD, Kidd MA. 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 2004; 99:23-32. (Pubitemid 38679096)
28. Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D. Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol 2009; 15:2177-2183.
29. Arnold R, Chen YJ, Costa F, Falconi M, Gross D, Grossman AB, et al. Mallorca consensus conference participants; European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: follow-up and documentation. Neuroendocrinology 2009; 90:227-233.